Singleron Partners with TOMY to Expand Single Cell Offerings in Japan 20.11.20242’Cologne, November 20, 2024 – Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with TOMY Digital Biology Co., Ltd. Under this agreement, TOMY will serve as Singleron’s exclusive distributor in Japan, providing access to Singleron’s comprehensive range of single cell analysis products and services.TOMY will distribute Singleron’s innovative offerings, which cover tissue preservation and dissociation, multi-omic single cell library preparation, and advanced data analysis software and services. This partnership will help researchers streamline their single cell analysis workflow from sample to publication-ready data.Kenjiro Tominaga, Owner, President and CEO of TOMY expressed enthusiasm about this collaboration, stating, “We see tremendous potential in Singleron’s unique single cell analysis solutions. Specifically, their easy-to-use, instrument-free single cell analysis options are a significant value add for Japanese researchers, providing them with greater flexibility.”Japan is one of the largest single cell markets in Asia. In addition to a robust single cell analysis platform, Singleron’s solutions address multiple challenges in the market, including time-consuming and labor-intensive sample preparation as well as the need for bioinformatics support for downstream data analysis.Jonathan Scolnick, General Manager of Singleron Biotechnologies APAC, remarked, “We are honored to collaborate with TOMY and are eager to serve our customers in Japan. TOMY’s extensive expertise in molecular biology and next-generation sequencing solutions will empower them to effectively support the single cell analysis needs of Japanese researchers. Together, we are committed to delivering high-quality data to help scientists achieve their next breakthroughs.”Singleron has recently announced distribution partnerships in India and Malaysia. This partnership with TOMY marks a significant step in Singleron’s continued expansion in Asia, addressing the growing demand for innovative single cell analysis solutions in the region.About Singleron BiotechnologiesSingleron Biotechnologies advances precision medicine and human health through pioneering single cell multi-omics solutions. Its current product portfolio includes high throughput instruments for automated single cell processing and tissue dissociation, reagents, bioinformatics software, and a comprehensive single cell knowledgebase.Founded in 2018, Singleron operates globally with offices, laboratories, and manufacturing facilities in Germany, Singapore, China, and the US. Its products are used in more than 3,000 laboratories in hospitals, research institutes, and pharmaceutical companies.For more information about Singleron’s products and services, please visit https://singleron.bioAbout TOMY Digital Biology Co., Ltd.TOMY Digital Biology Co., Ltd. spun off from TOMY Seiko, a manufacturer of scientific research instruments in 2001. TOMY Digital Biology has two functions, import and export. One department imports unique life science research products from other countries and distributes them to the Japan market. The other department exports TOMY products to other countries.For more information about TOMY’s products and services, please visit https://www.digital-biology.co.jpCheck out our latest news and events Learn more 24.10.28 B2B-RARE: Bench to Bedside – Rapid Diagnosis and Personalized Treatment of Rare Neuromuscular Diseases For the German version of the article, see here. NRW, 28th October 2024 – More than 400 genetically determined neuromuscular diseases (NME) are rare diseases…. Read more 24.10.08 Singleron and Bioscreen Announce Strategic Partnership to Enhance Access to Single Cell Multi-Omics Solutions for India Researchers Cologne, October 8, 2024 – Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor… Read more 24.09.11 Singleron Launches New All-in-One sCelLiVE® Tissue Dissociation Kit for Skin Cologne, 11th September 2024 – Singleron announced the launch of sCelLiVE® Tissue Dissociation Kit (Skin) (sCelLiVE Skin), a new all-in-one solution for human and mouse skin tissue…. Read more
24.10.28 B2B-RARE: Bench to Bedside – Rapid Diagnosis and Personalized Treatment of Rare Neuromuscular Diseases For the German version of the article, see here. NRW, 28th October 2024 – More than 400 genetically determined neuromuscular diseases (NME) are rare diseases…. Read more
24.10.08 Singleron and Bioscreen Announce Strategic Partnership to Enhance Access to Single Cell Multi-Omics Solutions for India Researchers Cologne, October 8, 2024 – Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor… Read more
24.09.11 Singleron Launches New All-in-One sCelLiVE® Tissue Dissociation Kit for Skin Cologne, 11th September 2024 – Singleron announced the launch of sCelLiVE® Tissue Dissociation Kit (Skin) (sCelLiVE Skin), a new all-in-one solution for human and mouse skin tissue…. Read more